Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1963 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1963 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Oncology
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation is…
25 Mar 2026 NCT06252649
● Recruiting Phase I Oncology
A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours
A Study of ATTR-01 in Participants With Select Epithelial Solid Tumours is Recruiting • Phase I • Oncology • NCT06977737. ATTR-01 is the experimental…
25 Mar 2026 NCT06977737
● Recruiting Oncology
Cancer Loyalty Card Study 2 (CLOCS-2)
Cancer Loyalty Card Study 2 (CLOCS-2) is Recruiting • Phase not applicable • Oncology • NCT06447064. Cancer is one of the leading causes of…
25 Mar 2026 NCT06447064
● Recruiting Cardiology / Cardiovascular
J-Valve Transfemoral Pivotal Study
J-Valve Transfemoral Pivotal Study is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT06455787. The primary objective of this study is to…
25 Mar 2026 NCT06455787
● Recruiting Phase I Cardiology / Cardiovascular
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease is Recruiting • Phase I • Cardiology / Cardiovascular •…
25 Mar 2026 NCT06164730
● Recruiting Oncology
GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis
GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis is Recruiting • Phase not applicable • Oncology • NCT06166537. Individuals attending…
25 Mar 2026 NCT06166537
● Recruiting Phase II Oncology
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis is Recruiting • Phase II • Oncology •…
25 Mar 2026 NCT06046222
● Recruiting Phase III Infectious Disease
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance…
25 Mar 2026 NCT05243797
● Recruiting Phase III Oncology
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer is Recruiting…
25 Mar 2026 NCT06119581
● Recruiting Phase II Oncology
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form…
25 Mar 2026 NCT04534205
● Recruiting Phase III Cardiology / Cardiovascular
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera is Recruiting • Phase III • Cardiology / Cardiovascular •…
25 Mar 2026 NCT06093672
● Recruiting Phase II Oncology
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable…
25 Mar 2026 NCT06567782
● Recruiting Oncology
Enabling Genomic Testing in Cancer of Unknown Primary
Enabling Genomic Testing in Cancer of Unknown Primary is Recruiting • Phase not applicable • Oncology • NCT06695494. Cancer of Unknown Primary (CUP) is…
25 Mar 2026 NCT06695494